BTA stat®, NMP22® BladderChek®, UBC® Rapid Test, and CancerCheck® UBC® rapid VISUAL as urinary marker for bladder cancer: Final results of a German multicenter study

Thorsten H. Ecke,Christina J. Meisl,Thorsten Schlomm,Anja Rabien,Flora Labonté,Dezhi Rong,Sebastian Hofbauer,Frank Friedersdorff,Lilli Sommerfeldt,Nella Gagel, Andreas Gössl,Dimitri Barski,Thomas Otto,Camilla M. Grunewald,Günter Niegisch,Martin J.P. Hennig,Mario W. Kramer,Stefan Koch,Jenny Roggisch,Steffen Hallmann

Urologic Oncology: Seminars and Original Investigations（2023）

引用 0|浏览12

暂无评分

摘要

•First multicenter study comparing urine-based rapid tests for bladder cancer.•Highest sensitivities for HGNMI bladder cancer for BTA stat® and UBC® Rapid Test.•Cytology should mostly be used in specialized centers.•Use of urinary-based rapid tests in management of bladder cancer should be discussed.

查看译文

关键词

bladderchek® cancercheck®,urinary marker

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要